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Noninvasive stress testing of myocardial
perfusion defects: head-to-head comparison
of thallium-201 SPECT to MRI perfusion
Gabriella Vincenti, MD,a Rene´ Nkoulou, MD,a Charles Steiner, MD,b
Hestia Imperiano, MD,b Giuseppe Ambrosio, MD,d Franc¸ois Mach, MD,a
Osman Ratib, MD,b Jean-Paul Vallee, MD,c and Thomas H. Schindler, MDa
Background. To evaluate the diagnostic value of magnetic resonance imaging (MRI) of
myocardial perfusion in the assessment of flow-limiting epicardial stenosis in a head-to-head
comparison with abnormal thallium-201 (201TI) single photon emission tomography (SPECT)
studies in patients with predominantly known coronary artery disease (CAD).
Methods and Results. Twenty-one patients (mean age 65 ± 10 years) with reversible
myocardial perfusion defects on 201TI-SPECT images during dipyridamole-stimulated hyper-
emia were recruited for study purpose. Within 5 days of the 201TI-SPECT study, myocardial
perfusion was studied again with MRI during dipyridamole stimulation and at rest. Overall,
201TI-SPECT identified 30 reversible regional perfusion defects. The sensitivity to detect hyp-
operfused segments was 70% (21/30) with the GRE-MRI perfusion analysis with 201TI-SPECT
as reference. When patients were subgrouped according to the extent of regional reversible
perfusion defects on 201TI-SPECT, mild- (SDS: 2-4), moderate- (SDS: 5-8), and severe-
(SDS > 8) perfusion defects were also identified by GRE-MRI perfusion analysis in 75% (6/8),
in 56% (9/16) and 100% (6/6), respectively.
Conclusions. GRE-MRI first-pass stress perfus\ion imaging may not identify up to 30% of
mild-to-moderate perfusion defects in a group of preselected patients with predominantly
known CAD and abnormal 201TI-SPECT studies. (J Nucl Cardiol 2009;16:549–61.)
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INTRODUCTION
According to the ischemic cascade,1 stress-induced
reductions in regional myocardial perfusion as a con-
sequence of flow-limiting epicardial stenosis commonly
precede a reduction in systolic function. Nuclear imag-
ing, therefore, has focused on imaging of myocardial
perfusion during bicycle-exercise or pharmacologic
vasodilation and at rest for the identification of flow-
limiting epicardial stenoses. Numerous studies have
shown a higher sensitivity for nuclear perfusion imaging
than for stress echocardiography with evaluation of
regional systolic function (85% vs 75%) in the detection
of the CAD process, while a higher specificity was
observed for stress echocardiography (88% vs 79%).2,3
More recently, cardiac magnetic resonance imaging
(MRI) has emerged as a new and promising cardiac
imaging modality to assess myocardial perfusion at rest
and during pharmacologically induced hyperemia using
gadolinium contrast agent and intravascular first-pass
imaging.4 In a total of 15 studies comprising 355
patients, MR first-pass perfusion imaging during vaso-
dilator stress revealed a mean sensitivity of 77% and
specificity of 85%.5 In particular, MRI affords the
advantage of a spatial resolution as high as 2-3 mm that
even enables the imaging of stress-induced subendo-
cardial flow reductions.6 Conversely, scintigraphic
myocardial perfusion imaging with thallium-201 (201TI)
and single photon emission tomography (SPECT)
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provides relatively high contrast resolution owing to the
high myocardial first-pass extraction fraction of 201TI as
high as 80-85%.7 While myocardial scintigraphy with
201TI-SPECT has a low effective spatial resolution of
about 20 mm, its high contrast resolution may allow the
detection of even mild regional differences of the
myocardial perfusion during bicycle-exercise stress or
pharmacologically induced hyperemia.8-10 This may
allow not only the identification of advanced flow-lim-
iting epicardial lesions but also of early stages of
subclinical and diffuse CAD as it has also been descri-
bed for PET imaging.8,9,11,12 Currently, the diagnostic
value of MR first-pass perfusion imaging in the identi-
fication of flow-limiting epicardial lesions as compared
to cardiac SPECT as reference remains uncertain.
In view of marked differences in the methodology
of cardiac 201TI-SPECT and MRI, we aimed to evaluate
the diagnostic value of MR perfusion imaging in the
assessment of flow-limiting epicardial stenosis in a
head-to-head comparison with abnormal 201TI-SPECT
studies in patients with predominantly known coronary
artery disease (CAD).
PATIENTS AND METHODS
Twenty-one patients (mean age 65 ± 10 years, 20
men, 1 women) with a history of angina pectoris and
predominantly known CAD were studied (Table 1). Of
these patients, 14 patients had had previous myocardial
infarction (Table 2). 201TI-SPECT was performed using
standard protocol with dipyridamole-induced hyperemic
flow increases and redistribution images after 4 hours.
Only patients with 201TI-SPECT identified reversible
perfusion defects were recruited for study purpose. In
these patients, fast gradient-echo (GRE) magnetic res-
onance (MR) first-pass perfusion imaging was
performed within 5 days of the 201TI-SPECT study
applying the same vasomotor-stress protocol. Coronary
angiography was performed within 2 weeks of cardiac
perfusion imaging studies. Between cardiac perfusion
imaging and coronary angiography, no clinical events
were noted. Any anti-ischemic medication was stopped
at least 12 hours before each study. In addition, no
patient consumed beverages containing caffeine (tea,
coffee, coca-cola, and chocolate) at least 24 hours
before each cardiac perfusion study. None of the patients
had a history of bronchial asthma and none was taking
aminophylline or related medication.
THALLIUM-201 MYOCARDIAL PERFUSION
IMAGING
For myocardial perfusion imaging with 201Tl-
SPECT, we used a standard protocol with imaging
acquisition immediately after increasing coronary flow
due to dipyridamole stimulation and redistribution
images after 4 hours. Dipyridamole was infused over
4 minutes (total dose 0.56 mg/kg), monitoring ECG and
blood pressure every minute, followed by an injection of
1.5 MBq/kg of 201TI 3 min from the end of the dipy-
ridamole infusion. The myocardial perfusion data were
acquired with SPECT using standard acquisition proto-
cols. SPECT images were obtained with a rotating
camera (CardioMD, Philips Medical Systems). Thirty-
two planar images (64 9 64 pixel matrix, 400 mm field
of view, 60 s per image) were acquired over a 180 arc
from the right anterior oblique position to the left pos-
terior oblique position. From the transaxial tomograms,
short-axis and long-axis myocardial slices were reori-
ented and the corresponding polar maps were submitted
to visual and semiquantitative analysis.13
Before image acquisition, a 5-s transmission scan
over the heart was performed to acquire a valid attenu-
ation map. Tomographic reconstruction was performed
with AutoSpect and Vantage Pro programs (Philips
Medical Systems).13 All emission images were auto-
matically corrected for nonuniformity, radioactive
decay, and motion during acquisition. The noncorrected
stress scintigraphic perfusion images were reconstructed
by filtered back-projection with a Butterworth filter
Table 1. Patient characteristics
n 21
Sex, F/M 1/20
Age, years 65 ± 10
BMI, kg/m2 27 ± 3
Obesity 8 (38)
Hypertension 14 (66)
Diabetes mellitus 7 (33)
Hypercolesterolemia 16 (76)
Smoking 16 (76)
CAD in family 9 (43)
Medication
Beta-Blockers 15 (71)
ACE-Inhibitor 14 (66)
Calcium-channel blocker 8 (38)
Nitrate 4 (19)
LVEF (%) 52 ± 9
Known CAD 19 (90)
Vessel disease
Single 3 (16)
Double 5 (26)
Triple 11 (58)
Myocardial infarction 14 (66)
Values are mean ± SD or n (%).
BMI, Body mass index; LVEF, left-ventricular ejection fraction.
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(order, 5; cutoff, 0.66). Attenuation maps, corrected for
201TI downscatter, were reconstructed by use of a
Bayesian prior approach after logarithmic inversion and
normalization to a reference scan and the application of
a Butterworth filter (order, 5; cutoff, 0.50).
MAGNETIC RESONANCE IMAGING
A 1.5 T scanner (Siemens Magnetom Espree) with
a phased-array receiver coil was used. Balanced steady-
state free precession (SSFP) cine imaging (parallel
imaging technique GRAPPA 2) with retrospective gat-
ing was acquired in vertical long axis (two chambers),
horizontal long axis (four chambers), and in multiple
short-axis views covering the left ventricle, for the
assessment of left ventricular function. Typical param-
eters were repetition time (TR) 3.42 ms, echo time (TE)
1.51 ms, flip angle 50, leading to a spatial resolution of
1.8 9 1.3 9 8 mm3. Subsequently, dipyridamole
(0.56 mg/kg) was infused over 4 minutes monitoring
ECG and blood pressure every minute. Three minutes
after finishing the dipyridamole infusion (waiting peak
vasodilation), bolus injection of gadolinium contrast
(0.1 mmol/kg Gadoteric acid, Dotarem, Guerbet) was
performed. MR first-pass stress perfusion study was
acquired in three short-axis planes (basal, middle, and
apical) and in one vertical long-axis plane every one heart
beat (single shot acquisition) with a saturation-recovery
turbo-FLASH gradient-echo (GRE) sequence, delayed
time of 90 ms, and parallel imaging technique read out
(GRAPPA 3). Typical parameters were repetition time
(TR) 1.92 ms, echo time (TE) 0.88 ms, and flip angle 15,
leading to a spatial resolution of 2.9 9 3 9 8 mm3.
Additional gadolinium 0.1 mmol/kg was injected for the
delayed contrast enhancement imaging acquired after
10 minutes to allow for the clearance of the first contrast
agent injection. Delayed enhancement (DE)-MRI was
performed with a segmented FLASH 3D inversion-
recovery technique: inversion time set to null normal
myocardium. Additional PSIR 2D sequences were
acquired in the vertical long axis, horizontal long axis,
and short-axis planes for a more accurate analysis of
the hyper-enhanced regions. After the acquisition of
the first-pass stress perfusion images, 240 mg aminoph-
ylline was administered intravenously in order to reverse
the vasodilatory effects of dipyridamole and, thereby,
Table 2. Angiographic (percentage luminal narrowing) data, perfusion abnormalities on 201Tl-SPECT
and GRE-MRI
Patient
no. LM LAD LCX RCA
Infarct
location
201Tl-SPECT
Perfusion
abnormalities
201Tl-SPECT
Perfusion
abnormalities
MRI
1 – – – 100 Lat, Inf Inf, Sep Inf, Sep
2 – 100 72 – Inf Ant, Lat –
3 – – 61 100 Inf Inf Inf
4 – 64 100 100 – Lat, Inf Lat, Inf
5 – 57 100 100 – Lat, Inf Lat, Inf
6 – – 100 100 Lat, Inf Lat, Inf Lat, Inf
7 – – 100 100 – Inf –
8 – 98 – 56 Inf Ant, Lat –
9 – 65 53 75 – Inf –
10 – 100 – 56 Ant, Sep Ant, Sep –
11 – 100 – 100 Ant, Sep, Inf Ant, Sep, Inf –
12 – – – 88 – Inf –
13 – 100 – – Ant Ant, Sep Ant, Sep
14 – 89 – – Ant Ant, Sep Ant, Sep
15 – – 86 – – Lat, Inf –
16 – – 83 – Lat, Inf Lat, Inf Lat, Inf
17 – 100 – – – Ant, Sep Ant, Sep
18 – 100 100 – Inf Ant, Inf Ant, Inf
19 – 100 – 100 Inf Ant, Inf Ant, Inf
20 – 100 – 100 Inf Ant, Inf Ant, Inf
21 – 61 79 92 Inf Lat, Inf Lat, Inf
–, No abnormality; Ant, anterior wall; Sep, interventricular septum; Lat, lateral wall; Inf, inferior wall; LM, left main artery; LAD, left
anterior descending artery; LCX, left circumflex artery; RCA, right coronary artery.
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to avoid lingering effects of dipyridamole on the
assessment of rest perfusion following the stress pro-
tocol. Subsequently, first-pass perfusion imaging was
repeated at rest using the same dose of contrast agent
(0.1 mmol/kg).
IMAGE ANALYSIS
Myocardial Scintigraphy
Visual interpretation was performed on eight short-
axis planes (from apex to base), eight vertical long-axis
planes and eight horizontal long-axis planes both during
stress test and at rest (total of 24 slices). Segments with
‘‘reversible’’ perfusion defects were considered ische-
mic while segments with ‘‘fixed’’ perfusion defects
during stress and at rest identified necrosis. Quantitative
and observer-independent evaluation of 201Tl-SPECT
was performed using a 20-segment model.14 Each seg-
ment was scored using a 5-point scoring system
(0 = normal, 1 = mildly, 2 = moderate, 3 = severe
reduction of radioisotope uptake, and 4 = apparent
absence of detectable tracer uptake in a segment). A
summed stress score (SSS) was obtained by adding the
scores of the 20 segments of the stress images.14 Simi-
larly, a summed rest score (SRS) was obtained by adding
the scores of the 20 segments on the rest images. For the
assessment of the extent of myocardial ischemia, a
summed difference score (SDS) was calculated by sub-
tracting the SRS from the SSS. A SSS \ 4 was
considered normal, 4–8 mildly abnormal, 9–13 moder-
ately abnormal, and[13 severely abnormal perfusion.14
Further, a SDS C 2 identified ischemia, while a
SDS \ 2 was considered a normal. The extent of
regional reversible perfusion defects on 201TI-SPECT
was graded according the SDS value. According to this,
a SDS of C2-4, [5-8, and [8 defined mild, moderate,
and severe reversible perfusion defects, respectively.
Finally, the left-ventricular ejection fraction (LVEF) at
rest and after dipyridamole stress test was evaluated by
gated SPECT.
MR Perfusion Imaging
MR stress and rest perfusion images and delayed
enhancement images in equivalent slices were evaluated
by two independent observers according to the AHA
17-segment model.15 Two expert observers, aware of the
results of the 201TI-SPECT study, independently evalu-
ated the MR perfusion images, and in the case of
disagreement between both observers, consent was
achieved in a joint reading. The analysis of perfusion
images was visual, based on gadolinium signal intensity
on first-pass images during vasomotor stress and its
difference from the images at rest. GRE-MR gadolinium
first-pass stress and rest perfusion images of three short-
axis planes (basal, middle, and apical) and in one ver-
tical long-axis plane were visually compared side-by-
side. Abnormal perfusion was defined as a signal
reduction (myocardium being black) at the peak bolus
during stress test but not at rest; normal perfusion was
defined as myocardium being bright both during stress
and at rest. Criteria indicative for true hypoperfusion vs
artifacts were subendocardial signal intensity reduction
persisting longer than the contrast-medium first-pass
through the left ventricle cavity (susceptibility artifacts
tend to be worst during peak concentration of gadolin-
ium in the RV and LV cavities and tend to disappear
rapidly), signal intensity reduction in several slices,
perfusion defect tending to follow the typical perfusion
territory of a coronary artery, absence of breathing
motion, and triggering artifacts during CM first-pass.16
Ischemic segments were scored with a four-point scale:
0, normal; 1, probably normal; 2, probably abnormal; 3,
definitely abnormal. This scoring system was chosen to
allow dichotomization of results into normal (B1) and
abnormal (C2). Hyperenhanced regions on DE-CMR
were assumed to represent myocardial infarction unless
isolated midwall or subepicardial hyperenhancement
was found.17 Necrosis appeared hyper-enhanced com-
pared with normal myocardium in delayed
enhancement. In presence of necrosis, residual ischemia
was defined as perfusion defect more extensive than the
region of delayed enhancement.
Coronary Angiography
Standard coronary angiography of the left and right
coronary arteries in multiple views was performed
according to the Judkins technique. Angiograms were
analyzed visually by two experienced observers who
identified the stenotic segments. The luminal diameter of
the stenosed artery was evaluated with quantitative
coronary angiography (QCA) in the projection that
demonstrated the most severe stenosis. Morphologically
significant stenosis was defined as C50% diameter
stenosis.
Statistical Analysis
Data are presented as mean ± SD for quantitative
and absolute frequencies for qualitative variables. For
comparison of differences, appropriate t tests for inde-
pendent or paired samples were used (Statistical
Analysis Software Institute, Cary, NC, USA). Differ-
ences in the agreement of myocardial perfusion defects
were analyzed with the x2 test. Two-tailed P values
\0.05 were considered to be statistically significant.
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RESULTS
Clinical Characteristics
Table 1 summarizes the characteristics of the study
population. All patients had a history of angina pectoris,
19 with known CAD and two with suspicion for CAD.
Of these, 14 had previous nontransmural myocardial
infarction. The mean LVEF as determined by gated
SPECT was 52 ± 9%. When a significant epicardial
coronary artery lesion during coronary angiography was
defined as C50% diameter stenosis, 11 patients had three
vessel disease, 5 two vessel disease, and 3 one vessel
disease. Most patients had hypercholesterolemia and
smoking, followed by arterial hypertension, family his-
tory of CAD, type 2 diabetes mellitus, and obesity as
defined by body mass index C30 kg/m2 .
Myocardial Perfusion Imaging
Figure 1 illustrates an example of a myocardial
perfusion defect in the antero-septo-apical wall during
dipyridamole stimulation on polar maps and three-
dimensional (3D) 201TI-SPECT images in a 64-year-old
and asymptomatic diabetic patient (Fig. 1A) as well as
on a mid-ventricular short-axis plane on GRE-MR first-
pass imaging (Fig. 1B). The stress-induced regional
perfusion defect was related to high grade epicardial
lesions in the proximal and middle artery segment of the
left-anterior descending artery (LAD) as shown on cor-
onary angiography (Fig. 1C).
Conversely, Fig. 2 demonstrates an example of a
42-year-old chronic smoker, who had had an acute
coronary syndrome (ACS) 5 days before the imaging
study. Coronary angiography demonstrated a 50% ste-
nosis of the proximal right coronary artery (RCA) as
well as a 90% stenosis of posterior descending artery
(PDA) (Fig. 2A). Subsequently, a cardiac 201TI-SPECT
study was performed to evaluate the hemodynamic
significance of these stenoses. Figure 2B depicts a
stress-induced myocardial perfusion defect in the infe-
rior wall on polar maps and 3D 201TI-SPECT images,
which was not seen on the basal and mid-ventricular
short-axis plane on GRE-MR first perfusion imaging
(Fig. 2C). The hemodynamic significance of the ste-
noses of the RCA were also evidenced by the post-stress
gated SPECT identified hypokinesia in the territory of
the stress-induced myocardial perfusion defect in the
inferior wall not seen on resting gated SPECT, indica-
tive of myocardial stunning.
In 21 patients predominantly with known mul-
tivessel disease, however, 201TI-SPECT with stress and
redistribution images identified 30 regional reversible
perfusion defects (abnormal SSS C 4 and SDS C 2)
(Tables 2 and 3). The mean SRS, SSS, and SDS were
9 ± 8, 18 ± 9, and 9 ± 4, respectively. All reversible
perfusion defects on 201TI-SPECT were subtended to
epicardial lesions [75% diameter stenosis as evidenced
by QCA (Table 2). Reversible perfusion defects of the
inferior and infero-lateral wall were confirmed on
attenuation-corrected 201TI-SPECT images (Table 2).
Coronary artery lesions for these reversible perfusion
defects ranged from 75% to 100% diameter stenosis
with a mean value of 93 ± 9%. On a patient-based
analysis, mild- (SDS: 2-4), moderate- (SDS: 5-8), and
severe- (SDS [ 8) reversible perfusion defects were
observed in 14% (3/21), 47% (10/21), and 38% (8/21)
on 201TI-SPECT. Conversely, on a vessel-based analy-
sis, there were 27% (8/30) mild-, 57% (16/30) moderate,
and 20% (6/30) severe reversible perfusion defects
(Table 3). In these patients with 30 regional reversible
scintigraphic perfusion defects on 201TI-SPECT, GRE-
MRI of myocardial perfusion during dipyridamole
stimulation and at rest detected 21 regional perfusion
defects (Tables 2, 3, Fig. 3). As can be seen in Table 3,
there was a good agreement of 70% (21/30) of regional
perfusion defects during pharmacologic vasodilation
between 201TI-SPECT and GRE-MRI, while nine
regional perfusion defects as defined by 201TI-SPECT
were not necessarily identified on GRE-MR images.
This difference achieved statistical significance
(P B 0.001). Of these 201TI-SPECT defined nine
regional reversible perfusion defects, that were not
identified by GRE-MRI, four were scored as ‘‘proba-
bly’’ normal (perfusion score of one), and five as
definitively normal on GRE-MRI. The segments scored
as ‘‘probably normal’’ on GRE-MRI corresponded to
two mild and two moderate reversible perfusion defects
on 201TI-SPECT, whereas the five segments scored as
‘‘definitively normal’’ on GRE-MRI corresponded to
moderate ischemia on 201TI-SPECT. The disagreement
between both modalities was seen myocardial segments
with and without previous myocardial infarction
(Tables 2 and 3). In regions with previous myocardial
infarction, 5 out of 17 residual myocardial ischemia as
denoted by 201TI-SPECT were not identified by GRE-
MRI. In these 17 patients, both delayed enhancement
MRI and 201TI-SPECT denoted infarcted regions. While
201TI-SPECT also identified a significant reversibility of
stress-rest perfusion in the infarcted area indicative for
peri-infarctial ischemia, this was not observed in five of
these cases where perfusion MRI demonstrated a mat-
ched stress-rest perfusion defect corresponding to the
delayed enhancement images. Conversely, in patients
without previous myocardial infarction, 201TI-SPECT
defined 13 reversible regional perfusion defects, of
which four were not demonstrated on GRE-MR stress
perfusion images.
Journal of Nuclear Cardiology Vincenti et al 553
Volume 16, Number 4;549–61 201TI-SPECT and MRI perfusion comparison
Figure 1. A Polar maps and three-dimensional (3D) 201TI-SPECT images with a perfusion defect
in the antero-septo-apical region during dipyridamole stress test that widely resolves on the resting
perfusion SPECT images (SSS = 20; SRS = 2; SDS = 18). B The myocardial perfusion defect
seen on polar maps and 201TI-SPECT was confirmed by cardiac GRE-MR first-pass perfusion
imaging shown here on a short-axis plane during dipyridamole-stimulated hyperemia (left panel) as
compared the corresponding short-axis plane at rest (right panel). C Coronary angiography
demonstrated a stenosis [90% of proximal and middle segment of the left anterior descending
artery (LAD).
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When patients were subgrouped according to the
extent of reversible perfusion defects on 201TI-SPECT,
mild- (SDS: 2-4), moderate- (SDS: 5-8), and severe-
(SDS [ 8) perfusion defects were also identified by
GRE-MRI perfusion analysis in 75% (6/8), 56% (9/16),
and 100% (6/6), respectively (Tables 2, 3 and Fig. 4).
Table 2 summarizes the head-to-head comparison of
201TI-SPECT and GRE-MRI for detecting reversible
myocardial perfusion defects in the individual coronary
artery. As can be appreciated, some disagreement was
Figure 2. A Coronary angiography demonstrates a 50% stenosis of the proximal right coronary
artery (RCA) as well as a 90% stenosis of posterior descending artery (PDA). Subsequently, a
201TI-SPECT perfusion study was performed to evaluate the hemodynamic significance of these
stenoses. B Polar maps and 3D 201TI-SPECT images identify a myocardial perfusion defect in the
inferior wall during dipyridamole stimulation that widely resolves on the resting perfusion SPECT
images (SSS = 18, SRS = 7, SDS = 11). C The reversible myocardial perfusion defect denoted
on 201TI-SPECT was not demonstrated by perfusion cardiac GRE-MR first-pass perfusion imaging
on the basal and mid-ventricular short-axis plane during stress (left panel) and rest on
corresponding short-axis planes (right panel).
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observed in all three coronary territories. In addition, the
extent of reversible perfusion defects on 201TI-SPECT
images was grouped according to quartile analysis with
SDS 2-4 (lowest quartile), SDS [ 4-6 (lower quartile),
SDS [ 6-8 (higher quartile), and SDS [ 8 (highest
quartile). Figure 5 demonstrates that the disagreement
between 201TI-SPECT and MRI was two in the lowest
quartile, three in the lower quartile, and four in the
higher quartile, while no disagreement was observed in
the highest quartile. Overall, 30% (9/24) of mild-to-
moderate regional reversible scintigraphic perfusion
defects were not necessarily identified by cardiac MR
perfusion imaging, while all six severe reversible per-
fusion defects were identified by both cardiac perfusion
imaging modalities. Differences in hemodynamic con-
ditions during pharmacologically induced hyperemia
with dipyridamole during 201TI-SPECT and subsequent
GRE-MRI, however, may have affected the identifica-
tion of stress-induced ischemia by GRE-MRI. As
Table 3. Head-to-head comparison of 201TI-SPECT and GRE-MRI for the detection of reversible myocardial
perfusion defects in the individual coronary artery segment
Artery
Mild ischemia Moderate ischemia Severe ischemia Total ischemia
SPECT MRI % SPECT MRI % SPECT MRI % SPECT MRI %
LAD 3 1 33 (1/3) 4 2 50 (2/4) 4 4 100 (4/4) 11 7 65 (7/11)
LCX 3 3 100 (3/3) 4 3 75 (3/4) – – – 7 6 86 (6/7)
RCA 2 2 100 (2/2) 8 4 50 (4/8) 2 2 100 (2/2) 12 8 67 (8/12)
Total 8 6 75 (6/8) 16 9 56 (9/16) 6 6 100 (6/6) 30 21 70 (21/30)
Data in parentheses are numbers used to calculate percentages.
LAD, Left anterior descending artery; LCX, left circumflex artery; RCA, right coronary artery.
Mild ischemia: SDS = 2–4; moderate ischemia: SDS = 5–8; severe ischemia: SDS[8. % Sensitivity of MRI to
detect SPECT defined stress-induced perfusion defects.
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Figure 3. Head-to-head comparison of 201TI-SPECT identi-
fied myocardial perfusion defects during dipyridamole-
stimulated hyperemia with GRE-MR first-pass perfusion
imaging (*P B 0.05 vs 201TI-SPECT).
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Figure 4. Head-to-head comparison of 201TI-SPECT identi-
fied mild-, moderate- and severe regional myocardial perfusion
defects during dipyridamole-stimulated hyperemia with GRE-
MR first-pass perfusion imaging (*P B 0.05 vs 201TI-SPECT).
0
1
2
3
4
5
6
7
8
9
10
8 
6 
9
6
7
3
6  6 
Tl-201 SPECT
GRE- MRI
R
ev
er
si
bl
e 
Pe
rfu
si
on
 D
ef
ec
ts
   
(n) 
1. Quartile 2. Quartile 3. Quartile 4. Quartile 
*
* 
Figure 5. Head-to-head comparison of 201TI-SPECT identi-
fied myocardial perfusion defects grouped according to
quartile analysis of SDS with GRE-MR first-pass perfusion
imaging (*P B 0.05 vs 201TI-SPECT).
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denoted in Table 4, although the stress hemodynamic
responses during dipyridamole stimulation statistically
did not differ significantly at the time of both myocardial
perfusion imaging studies, they tended to be less during
GRE-MR perfusion imaging than during the 201TI-
SPECT exam. This could have affected, at least in part,
the lower detection rate of mild-to-moderate stress-
induced regional perfusion defects with GRE-MRI as
compared to 201TI-SPECT.
DISCUSSION
In the current study, we aimed to evaluate the
diagnostic value of GRE-MR perfusion imaging in the
assessment of hemodynamically obstructive CAD in a
head-to-head comparison with 201TI-SPECT as refer-
ence. As it was observed, there was a relatively good
concordance of 70% between cardiac 201TI-SPECT and
GRE-MRI in the detection of stress-induced regional
perfusion defects, while 30% of mild-to-moderate scin-
tigraphic perfusion defects were not necessarily
identified by cardiac GRE-MR perfusion imaging. These
observations agree somehow with results of previous
investigations in small numbers of patients with sus-
pected CAD,18 but extend the latter observations to a
larger study population in patients with predominantly
known CAD.
The reason for some discordant observation
between cardiac 201TI-SPECT and GRE-MR imaging in
the detection of stress-induced perfusion defects remains
uncertain but may be related, at least in part, to differ-
ences in the myocardial contrast resolution provided by
both cardiac imaging modalities. As regards SPECT
perfusion imaging, the myocardial first-pass extraction
fraction of 201TI from the blood into the myocardium is
as high as 80-85%.7 Beyond this first-pass extraction,
recirculation of 201TI in patients allows further extrac-
tion of the radiotracer with a further increase in signal-
to-noise ratio or contrast resolution. Conversely, as
coronary flow increases, less 201TI is directly extracted
during the capillary transit leading to as so-called ‘‘roll-
off’’ at high coronary flow levels.19 As a consequence,
201TI uptake is no longer linearly related to myocardial
blood flow above & 2.5 mL/g/min. The latter drawback
in fact may lead to difficulties of 201TI-SPECT in the
identification of mild regional perfusion differences
underlying flow-limiting epicardial lesions during higher
hyperemic flow increases above 2.5 mL/g/min.7,19
As regards the contrast agent gadolinium used for
GRE-MR perfusion imaging, it may diffuse rapidly
across the capillary membrane into the extracellular
space, while it may not enter myocytes with intact cell
membranes.20 Thus, about 30-50% of the gadolinium
first-pass bolus may enter the myocardial interstitium. It
follows then that the myocardial gadolinium concen-
tration is predominantly determined by the intravascular
space and thus the coronary flow. First-pass evaluation
of the myocardial gadolinium transit is necessary as
recirculation and bolus dilation leads to a rapid equili-
bration of the contrast between the vascular and
extravascular space, resulting in a disappearance of a
initial myocardial perfusion defect. Due to the latter
limitations, the contrast resolution of gadolinium
first-pass GRE-MR perfusion imaging is likely to be
lower than for myocardial retention of 201TI-retention
imaged with SPECT. Thus, as observed in the current
study, 201TI-SPECT with its high myocardial perfusion
contrast may be more sensitive to detect more mild-to-
moderate stress-induced perfusion defects than gado-
linium GRE-MR first-pass imaging. In fact, a survey of
the MR first-pass perfusion imaging literature may
support these considerations.5 According to this, a total
of 15 MR perfusion imaging studies with a total of 355
patients were summarized. MR perfusion imaging yiel-
ded an average sensitivity of 77% (ranging from 65% to
93%) and an average specificity of 83% (range, 60% to
100%). Conversely, the average sensitivity and speci-
ficity of 201TI-SPECT perfusion imaging during
Table 4. Hemodynamic response to dipyridamole stimulation
SPECT MRI
Rest Hyperemia Rest Hyperemia
HR, beats/min 71 ± 10 91 ± 17 70 ± 10 86 ± 19
SBP, mmHg 133 ± 17 139 ± 20 130 ± 19 129 ± 23
DBP, mmHg 79 ± 10 79 ± 11 71 ± 12 69 ± 14
RPP, mmHg 9 min 9523 ± 1805 12843 ± 3948 9085 ± 2045 11347 ± 4229
DRPP, mmHg 9 min 3320 ± 2143 2262 ± 2184
HR, Heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; RPP, rate-pressure product (HR 9 SBP); DRPP, change
of RPP from rest to hyperemia.
P = 0.09 for DRPP between SPECT vs MRI.
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dipyridamole stimulation for detecting angiographically
significant CAD (C50% stenosis) had been reported of
90% and 71%, respectively. Sensitivities ranged from
98% to 76%, with specificities ranging from 42% to
100%.7 Based on these data, the visual analysis of MR
perfusion imaging appears to be less sensitive than
SPECT in the identification of flow-limiting epicardial
lesion as also observed in the current study, while it may
offer a higher specificity. Conversely, MR first-pass
imaging with the semiquantitative assessment of an
index of myocardial perfusion reserve has been shown to
be a promising tool to delineate subendocardial perfu-
sion abnormalities in patients with cardiac syndrome X
and normal coronary arteries,21 and in a more quanti-
tative analytic approach to even identify mild
downstream hemodynamic effects of coronary artery
calcification on coronary flows during vasomotor stress
in patients with subclinical CAD.22 In patients with
multivessel CAD, however, the myocardial flow reserve
may be reduced in more or less homogenous fashion,23
associated with a insufficient regional perfusion dispar-
ity to identify underlying flow-limiting epicardial
disease. Under such circumstances, therefore, flow-lim-
iting epicardial lesions may remain undetected on
conventional visual analysis of relative distributions of
the predominantly intravascular gadolinium contrast on
MRI or myocardial radiotracer uptake on SPECT ima-
ges.7,24,25 Under such condition, it is possible that the
higher contrast resolution of 201TI-SPECT may be more
sensitive to unravel mild differences in regional myo-
cardial perfusion during hyperemic flow increases that
may be missed by the visual analysis of cardiac MR
perfusion images. Our observations in patients with
predominantly multivessel CAD support such a possi-
bility as nine mild-to-moderate regional reversible
perfusion defects as determined by 201TI-SPECT were
not identified on GRE-MR first-pass perfusion imaging,
while none of six severe perfusion defects were missed.
Cardiac SPECT imaging, however, may be signifi-
cantly affected by artifacts due to photon absorption by
the breast, diaphragma, liver, and the thoracic wall
leading to false-positive perfusion findings. Conse-
quently, there is a need for attenuation correction by
assessing an attenuation map commonly acquired by
transmission scanning with external radioactive sources.
In particular, the inferior wall has been demonstrated to
benefit most from the attenuation correction to avoid
false-positive results.13,26 As we performed attenuation
correction for 201TI-SPECT perfusion images, it is
unlikely that some perfusion defects during pharmaco-
logic vasodilation were false-positive findings even
though we cannot entirely exclude such a possibility.
Also, all regional myocardial perfusion defects detected
on 201TI-SPECT perfusion images were related to
epicardial stenosis [75% diameter, as evidenced by
QCA, that may further emphasize the identification of
true perfusion abnormalities on 201TI-SPECT in the
current study.
Our results agree but also differ from a previous
comparative investigation between turbo fast FLASH-
MR and 201TI-SPECT perfusion imaging in 40 patients
with suspected CAD.27 Applying a morphologic cutoff
of [70% diameter stenosis of the coronary artery,
overall comparable sensitivities and specificities for
cardiac turbo-FLASH MRI and 201TI-SPECT of 81% vs
81% and 68% vs 63% were observed, respectively.
The relatively lower specificity for 201TI-SPECT as
compared to MRI may be explained by the fact that
201TI-SPECT perfusion images were acquired without
attenuation correction.27 An important limitation of the
latter study, however, was the heterogeneity in stress
testing with bicycle-exercise (n = 26) and pharmaco-
logic vasodilation (n = 14) for the 201TI-SPECT exam.
This difference in stress testing in fact may have com-
promised, at least in part, the comparison of the
diagnostic accuracy of both cardiac perfusion imaging
modalities in the same patient. Nevertheless, these
results were first to have indicated that MR first-pass
perfusion imaging may represent an alternative to stress
myocardial scintigraphy. This consideration is also
supported by more recent findings of the multicentre,
multivendor, and randomized MR-impact trial16 com-
paring the role of MR and SPECT perfusion imaging in
the detection of flow-limiting epicardial lesions in a
study population with relatively high CAD prevalence.
Based on a receiver operating characteristic (ROC)
analysis, MR perfusion imaging with adenosine stress
and an optimal dose of the contrast agent gadolinium
(0.1 mmol/kg) revealed a similar diagnostic perfor-
mance in the assessment of flow-limiting epicardial
lesions of C50% diameter stenosis as SPECT using
either 99mTc- or 201TI-tracers in a head-to-head com-
parison. Paradoxically, in the overall study population
without a head-to-head comparison and with various
doses of gadolinium ranging from 0.01 to 0.1 mmol/kg
for the MRI measurements of myocardial perfusion, MR
perfusion imaging apparently proved to be superior to
SPECT in the evaluation of flow-limiting epicardial
lesions. The reason for this remains uncertain but is
likely to be related to the underuse of gated SPECT
(&50%) and the absence of a proper attenuation cor-
rection of SPECT images associated with a higher rate
of false-positive findings. In view of the latter limita-
tions of the MR-impact trial,16 as the authors also state,
future head-to-head comparative trials between MR and
SPECT perfusion imaging are needed in patients with
low-, intermediate-, and high probability of CAD using a
proper methodology and expert reading.
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In general, sensitivities and specificities of myo-
cardial perfusion imaging of CAD depend on several
factors such as the patient population studied (i.e., the
pretest probability), criteria for CAD, criteria for posi-
tive perfusion defects, and imaging methods.28-30
Differences in these factors may not necessarily allow a
proper comparison of sensitivity and specificity values
of different investigations.31,32 A morphologic cutoff
such as 50% or 70% diameter stenosis is a rather poor
predictor of hemodynamic downstream effects of coro-
nary stenoses, in particular for intermediate-severity
lesions. Thus, comparative studies of different imaging
modalities in the assessment of myocardial perfusion in
the same patient as performed in the current study may
provide more specific and detailed information. It is
important to bear in mind, however, that the analysis of
201TI-SPECT in the current study was performed
quantitatively using the QPS software with a 20-segment
model.14 According to this, a SSS C 4 and SDS C 2
defined the presence of stress-induced myocardial
ischemia. Thus, on 201TI-SPECT regional myocardial
ischemia was defined according to scintigraphic criteria
in a quantitative and observer-independent fashion. In
the current study, the GRE-MRI analysis of myocardial
perfusion was based on a qualitative visual evaluation
and, thus, observer-dependent. This may have intro-
duced some observational error in the identification of
mild-to-moderate myocardial perfusion defects of car-
diac GRE-MR perfusion images. The visual analysis of
MR images is known to be hampered sometimes by
image artifacts. For example, transient dark rim artifact
(DRA) in the subendocardial layer may mimic a hyp-
operfused area and, thereby, limit the specificity of MR
perfusion imaging. The causes of the DRA have been
related to so-called Gibbs ringing at the blood–myo-
cardial interface, magnetic susceptibility due to the
bolus injection of gadolinium, banding movement arti-
facts, and partial volume effects between left-ventricular
blood pool and the myocardium.33 The DRA commonly
lasts for a few heart beats and varies temporally as the
gadolinium bolus passes through the left-ventricular
blood pool. In contrast, a true myocardial perfusion
defect tends to be more constant and visible for a longer
imaging duration than the DRA. Although an experi-
enced reader can differentiate between DRA and a real
perfusion defect by the transient variation of the DRA, it
is sometimes difficult to identify true mild-to-moderate
perfusion defects which ‘‘fill in’’ rapidly. In this regard,
recent investigations 34 suggest that a fixed DRA (stress-
rest perfusion defect) on MRI may be unmasked by
adding delayed enhancement imaging for the identifi-
cation or absence of myocardial infarction in the
corresponding territory. Such algorithm in fact may
increase the diagnostic accuracy in the detection of CAD
by incorporating the high specificity of delayed
enhancement MRI in a population with intermediate
probability of CAD and without prior myocardial
infarction.34 As the current study population had pre-
dominantly known CAD and previous nontransmural
myocardial infarction, the implementation of the
delayed enhancement MRI did not aid in the differen-
tiation between DRA and ischemic perfusion defects. In
the current study, however, some 201TI-SPECT revers-
ible perfusion defects may have been missed by the
observer-dependent visual analysis of GRE-MR images
due to the difficulties in differentiating between DRA
and ischemic perfusion defects. And indeed, four cases
with 201TI-SPECT defined mild-to-moderate regional
perfusion defects were estimated on GRE-MRI as
‘‘probably’’ normal in the presence of some kind of
DRA. Another possibility is that if a quantitative and
observer-independent analysis had been used for the
analysis of the GRE-MR images, these 201TI-SPECT
defined perfusion defects may have also been identified
by GRE-MRI. A previous investigation of cardiac MRI
for the detection of CAD35 assessed the diagnostic
accuracy of MR first-pass perfusion imaging in the
detection of CAD. The visual analysis of the MR per-
fusion images yielded a sensitivity of 70%, specificity of
78%, and diagnostic accuracy of 74% when a morpho-
logic significant stenosis was defined as C75% diameter.
Conversely, using a semiquantitative index of myocar-
dial perfusion reserve in the same study population did
lead to an improved sensitivity of 88%, specificity of
90%, and diagnostic accuracy of 89%. Similarly, Sch-
witter et al36 using a myocardial perfusion reserve index
observed a similar sensitivity and specificity of 87% and
85%, respectively, in detecting coronary artery lesions
of C50% diameter stenosis. Thus, the semiquantitative
assessment of an index of myocardial perfusion reserve
or, as it has been reported more recently,37 the fractional
flow reserve may indeed contribute to improve the
diagnostic performance of MR first-pass perfusion
imaging in the detection of flow-limiting epicardial
lesions.38 While such a semiquantitative approach to
assess MR first-pass perfusion imaging may contribute
to improve the identification flow-limiting epicardial
lesions, it is not yet standardized and time-consuming
that still limits a more widespread clinical use.
LIMITATIONS
There are important limitations worthy to be con-
sidered in interpreting the current study data. At first, the
study population consisted of patients with predominantly
with known CAD. The observations therefore could differ
among a population with a low- or intermediate risk for
CAD. Further comparative investigations are needed to
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evaluate the diagnostic role of MRI first-pass perfusion in
the detection of mild-, moderate-, and severe flow-limit-
ing stenosis in patients with suspected CAD. Second, as
we only included patients with 201TI-SPECT defined
ischemia as reference for the MR first-pass perfusion
imaging, the current evaluation was biased toward 201TI-
SPECT perfusion imaging. According to the latter, this
investigation does not allow the commonly comparison of
the assessment of sensitivity and specificity values of
different cardiac imaging modalities in the detection of
CAD in the clinical setting. Also, the myocardial perfu-
sion studies with 201TI-SPECT and GRE-MR first-pass
perfusion imaging were not analysed in a blinded manner
to each other that could have affected the interpretation of
the perfusion images. Third, in view of the relatively small
sample size of the study population with 201TI-SPECT
defined stress-induced perfusion defects, the current
investigation does certainly not permit definite conclu-
sions but may add to stimulate larger comparative
investigations between 201TI-SPECT and MR first-pass
perfusion imaging in patients with suspected and known
CAD.16
CONCLUSIONS
GRE-MRI first-pass stress perfusion imaging may
not identify up to 30% of mild-to-moderate perfusion
defects in a group of preselected patients with predom-
inantly known CAD and abnormal 201TI-SPECT studies
possibly related to a lower contrast resolution, technical
parameters, and/or absence of perfusion quantification.
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